Logo image of SES

SES AI CORP (SES) Stock Fundamental Analysis

NYSE:SES - New York Stock Exchange, Inc. - US78397Q1094 - Common Stock - Currency: USD

0.7955  -0.04 (-5.12%)

Premarket: 0.7897 -0.01 (-0.73%)

Fundamental Rating

3

Overall SES gets a fundamental rating of 3 out of 10. We evaluated SES against 93 industry peers in the Electrical Equipment industry. SES has a great financial health rating, but its profitability evaluates not so good. SES is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SES has reported negative net income.
SES had a negative operating cash flow in the past year.
In the past 5 years SES always reported negative net income.
SES had a negative operating cash flow in each of the past 5 years.
SES Yearly Net Income VS EBIT VS OCF VS FCFSES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

SES has a Return On Assets (-21.83%) which is in line with its industry peers.
The Return On Equity of SES (-24.70%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.83%
ROE -24.7%
ROIC N/A
ROA(3y)-9.62%
ROA(5y)-87.47%
ROE(3y)-10.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SES Yearly ROA, ROE, ROICSES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SES so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SES Yearly Profit, Operating, Gross MarginsSES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K

8

2. Health

2.1 Basic Checks

There is no outstanding debt for SES. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SES Yearly Shares OutstandingSES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
SES Yearly Total Debt VS Total AssetsSES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

SES has an Altman-Z score of 3.19. This indicates that SES is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.19, SES is doing good in the industry, outperforming 72.83% of the companies in the same industry.
There is no outstanding debt for SES. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.19
ROIC/WACCN/A
WACCN/A
SES Yearly LT Debt VS Equity VS FCFSES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 15.24 indicates that SES has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 15.24, SES belongs to the top of the industry, outperforming 97.83% of the companies in the same industry.
SES has a Quick Ratio of 15.22. This indicates that SES is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 15.22, SES belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.24
Quick Ratio 15.22
SES Yearly Current Assets VS Current LiabilitesSES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -24.82% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y5.52%
EPS Next 2Y-30.79%
EPS Next 3Y-30.68%
EPS Next 5Y-24.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SES Yearly Revenue VS EstimatesSES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
SES Yearly EPS VS EstimatesSES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5

0

4. Valuation

4.1 Price/Earnings Ratio

SES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SES. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SES Price Earnings VS Forward Price EarningsSES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SES Per share dataSES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

SES's earnings are expected to decrease with -30.68% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.79%
EPS Next 3Y-30.68%

0

5. Dividend

5.1 Amount

SES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SES AI CORP

NYSE:SES (2/26/2025, 8:06:48 PM)

Premarket: 0.7897 -0.01 (-0.73%)

0.7955

-0.04 (-5.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)N/A N/A
Inst Owners32.69%
Inst Owner Change-13.86%
Ins Owners0.93%
Ins Owner Change-19.45%
Market Cap286.84M
Analysts48
Price Target1.02 (28.22%)
Short Float %7.95%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.13%
Min EPS beat(2)22.52%
Max EPS beat(2)25.74%
EPS beat(4)4
Avg EPS beat(4)27.63%
Min EPS beat(4)0.99%
Max EPS beat(4)61.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS0.86
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.83%
ROE -24.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.62%
ROA(5y)-87.47%
ROE(3y)-10.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 205.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.24
Quick Ratio 15.22
Altman-Z 3.19
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y5.52%
EPS Next 2Y-30.79%
EPS Next 3Y-30.68%
EPS Next 5Y-24.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.94%
EBIT Next 3Y-7.04%
EBIT Next 5Y22.2%
FCF growth 1Y-68.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.75%
OCF growth 3YN/A
OCF growth 5YN/A